<SEC-DOCUMENT>0001140361-19-004564-index.html : 20190308
<SEC-HEADER>0001140361-19-004564.hdr.sgml : 20190308
<ACCEPTANCE-DATETIME>20190308070235
ACCESSION NUMBER:		0001140361-19-004564
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20190308
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190308
DATE AS OF CHANGE:		20190308

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRISTOL MYERS SQUIBB CO
		CENTRAL INDEX KEY:			0000014272
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				220790350
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01136
		FILM NUMBER:		19667584

	BUSINESS ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		2125464000

	MAIL ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRISTOL MYERS CO
		DATE OF NAME CHANGE:	19891012
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>s002621x24_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: s002621x24_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>s002621x24_ex23-1.htm
<DESCRIPTION>CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CELGENE CORPORATION.
<TEXT>
Document 2 - file: s002621x24_ex23-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>s002621x24_ex99-1.htm
<DESCRIPTION>THE HISTORICAL AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULE OF CELGENE CORPORATION, THE NOTES RELATED THERETO AND RELATED REPORT OF KPMG LLP.
<TEXT>
Document 3 - file: s002621x24_ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>s002621x24_ex99-2.htm
<DESCRIPTION>UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF BRISTOL-MYERS SQUIBB COMPANY GIVING EFFECT TO THE ACQUISITION OF CELGENE CORPORATION.
<TEXT>
Document 4 - file: s002621x24_ex99-2.htm

</DOCUMENT>
</SEC-DOCUMENT>